EVERSEPT PARTNERS, LP – Fate Therapeutics, Inc. Transaction History
EVERSEPT PARTNERS, LP portfolio value:
$3.17M
portfolio value
EVERSEPT PARTNERS, LP quarter portfolio value change:
-9.56%
quarter
Fate Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -80.52% | -585.02K shares | -14.83M | $22.41 | 141.55K |
Q2 2022 | share | Increase | +59.32% | 270.52K shares | 324K | $24.78 | 726.58K |
Q1 2022 | share | Increase | +78.99% | 201.26K shares | 2.77M | $38.77 | 456.05K |
Q4 2021 | share | Decrease | -2.34% | -6.10K shares | -555K | $60.07 | 254.79K |
Q3 2021 | share | Decrease | -24.67% | -85.45K shares | -14.59M | $59.27 | 260.89K |
Q2 2021 | share | Increase | +7.64% | 24.58K shares | 3.53M | $86.79 | 346.34K |
Q1 2021 | share | Decrease | -19.46% | -77.73K shares | -9.79M | $82.45 | 321.76K |
Q4 2020 | share | Decrease | -25.33% | -135.53K shares | 14.94M | $90.93 | 399.49K |
Q3 2020 | share | Increase | +0.71% | 3.77K shares | 3.15M | $39.97 | 535.03K |
Q2 2020 | share | Increase | +73.91% | 225.77K shares | 11.44M | $34.31 | 531.25K |
Q1 2020 | share | Decrease | -15.30% | -55.17K shares | -273K | $22.21 | 305.48K |
Q4 2019 | share | Increase | +156.41% | 220K shares | 4.87M | $19.57 | 360.65K |
Q3 2019 | share | Decrease | -35.44% | -77.2K shares | -2.23M | $15.53 | 140.65K |
Q2 2019 | share | Decrease | -37.76% | -132.15K shares | -1.72M | $20.3 | 217.85K |
Q1 2019 | share | Increase | +112.13% | 185.01K shares | 4.03M | $17.57 | 350.01K |
Q4 2018 | share | Increase | 0.00% | 165K shares | 2.11M | $12.83 | 165K |